About AdaptX
AdaptX is a company based in Seattle (United States) founded in 2016. It operates as a SaaS (Software-as-a-Service) and HealthTech. AdaptX has raised $29.81 million across 8 funding rounds from investors including Memorial Hermann, Cercano Management and Founders' Co-op. AdaptX offers products and services including AdaptX Platform. AdaptX operates in a competitive market with competitors including Evergreen Nephrology, Pathalys, Specialty Networks, Bial and Appello, among others.
- Headquarter Seattle, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$29.81 M (USD)
in 8 rounds
-
Latest Funding Round
$2.66 M (USD), Series A
Sep 15, 2025
-
Investors
Memorial Hermann
& 9 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AdaptX
AdaptX offers a comprehensive portfolio of products and services, including AdaptX Platform.
Clinical variation is managed using real-world data insights.
People of AdaptX
Unlock access to complete
Funding Insights of AdaptX
AdaptX has successfully raised a total of $29.81M across 8 strategic funding rounds. The most recent funding activity was a Series A round of $2.66 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in AdaptX
AdaptX has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include Memorial Hermann, Cercano Management and Founders' Co-op.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed and early-stage tech investments are made in the US.
|
Locked | Locked | Locked | |
|
Seed stage investments are offered by Fortson Venture Capital.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for AdaptX
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AdaptX
Investment portfolio details for AdaptX
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AdaptX
Detailed financials for AdaptX
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Adaptx Comparisons
Peer comparison for AdaptX
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AdaptX
AdaptX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evergreen Nephrology, Pathalys, Specialty Networks, Bial and Appello, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Chronic care management services for kidney diseases are provided.
|
|
| Locked | Locked | Locked |
Biotherapeutics for chronic kidney disease are developed and provided.
|
|
| Locked | Locked | Locked |
Specialty Networks is focused on supporting independent specialty healthcare providers.
|
|
| Locked | Locked | Locked |
Develops and commercializes pharmaceutical products through research and global distribution.
|
|
| Locked | Locked | Locked |
Chronic care management services are provided to patients.
|
Detailed competitors of AdaptX
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Adaptx
Complete news archive for AdaptX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AdaptX
AdaptX was founded in 2016 and raised its 1st funding round 2 years after it was founded.
AdaptX is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Warren Ratliff is the current CEO of AdaptX.
AdaptX is a funded company, having raised a total of $29.81M across 8 funding rounds to date.
Clinical variation across treatments, workflows, and teams is managed by AdaptX, a health technology company. Solutions are provided to clinical leaders in academic medical centers and hospitals to address capacity, revenue, quality, equity, and sustainability challenges. Real-world data is leveraged to optimize patient flow and improve operational efficiency. Sectors served include clinical operations, quality improvement, IT, and finance within healthcare institutions.
AdaptX's top competitors include Evergreen Nephrology, Pathalys and Brown & Toland.
AdaptX offers AdaptX Platform.
AdaptX has 10 investors. Key investors include Memorial Hermann, Cercano Management, Founders' Co-op, Fortson Venture Capital, and Star Equity Fund.